{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:37:04Z","timestamp":1747208224054,"version":"3.40.5"},"reference-count":47,"publisher":"Informa UK Limited","issue":"13","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Pharmacogenomics"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.2217\/pgs-2021-0023","type":"journal-article","created":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T13:32:16Z","timestamp":1629725536000},"page":"849-857","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Systematic Review of Pharmacogenomics Knowledgebase Evidence for Pharmacogenomic Links to the Dopamine Reward Pathway for Heroin Dependence"],"prefix":"10.1080","volume":"22","author":[{"given":"Maggie L","family":"McCorkle","sequence":"first","affiliation":[{"name":"The Ohio Attorney General\u2019s Office, Columbus, OH43215, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7215-7734","authenticated-orcid":false,"given":"David F","family":"Kisor","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences &amp; Pharmacogenomics, College of Pharmacy, Natural &amp; Health Sciences, Manchester University, Fort Wayne, IN46845, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9901-8419","authenticated-orcid":false,"given":"Caroline E","family":"Freiermuth","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, University of Cincinnati, Cincinnati, OH\ufffd\ufffd45267, USA"},{"name":"Center for Addiction Research, University of Cincinnati College of Medicine, Cincinnati, OH\ufffd\ufffd45267, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0349-5072","authenticated-orcid":false,"given":"Jon E","family":"Sprague","sequence":"additional","affiliation":[{"name":"The Ohio Attorney General\u2019s Office, Columbus, OH43215, USA"},{"name":"The Ohio Attorney General\u2019s Center for the Future of Forensic Science, Bowling Green State University, Bowling Green, OH43403, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,8,23]]},"reference":[{"key":"e_1_3_3_2_1","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA) . Key substance use and mental health indicators in the United States: results from the 2015 National Survey On Drug Use And Health. (2016). http:\/\/www.samhsa.gov\/data\/report\/key-substance-use-and-mental-health-indicators-united-states-results-2015-national-survey"},{"key":"e_1_3_3_3_1","unstructured":"Centers for Disease Control and Prevention (CDC) . Opioid painkiller prescribing varies widely among states (2014). http:\/\/www.cdc.gov\/media\/releases\/2014\/p0701-opioid-painkiller.html"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2019.12.023"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.09.022"},{"key":"e_1_3_3_6_1","unstructured":"National Safety Council (NSC) . Preventable deaths: odds of dying (2019). http:\/\/injuryfacts.nsc.org\/all-injuries\/preventable-death-overview\/odds-of-dying\/data-details\/"},{"key":"e_1_3_3_7_1","unstructured":"Centers for Disease Control and Prevention (CDC) . Opioid overdose (2020). http:\/\/www.cdc.gov\/drugoverdose\/epidemic\/index.html"},{"issue":"39","key":"e_1_3_3_8_1","first-page":"849","article-title":"Increases in heroin overdose deaths \u2013 28 States, 2010 to 2012","volume":"63","author":"Rudd RA","year":"2014","unstructured":"Rudd RA , PaulozziLJ , BauerMJet al. Increases in heroin overdose deaths \u2013 28 States, 2010 to 2012. MMWR Morb. Mortal. Wkly. Rep.63(39), 849\u2013854 (2014).","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6533a2"},{"key":"e_1_3_3_10_1","unstructured":"Centers for Disease Control and Prevention (CDC) . Applying CDC\u2019s guidelines for prescribing opioids: module 5: assessing and addressing opioid use disorder (OUD) (2018). http:\/\/www.cdc.gov\/drugoverdose\/training\/oud\/accessible\/index.html"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e31825a2a4e"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.55.11.967"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.57.3.261"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2017.19.3\/wberrettini"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/nn1578"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2350"},{"key":"e_1_3_3_17_1","unstructured":"Clinical Pharmacogenetics Implementation Consortium (CPIC) . (2020). http:\/\/cpicpgx.org\/"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1105418108"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2016.01.043"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-018-0225-3"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-183X.2008.00410.x"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2015.01.003"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-200105080-00011"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-1600.2012.00445.x"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-019-0497-y"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0166-4328(96)00061-7"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.2174\/187152708786927886"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2008.06.001"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2016.10.033"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2147780"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/41567"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/ahg.12322"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e328320a3fd"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/febs.15496"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2009.02.005"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087247"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2010.12.004"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.5055\/jom.2017.0392"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5849(01)00724-9"},{"issue":"4","key":"e_1_3_3_40_1","first-page":"644","article-title":"Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro","volume":"14","author":"Graham DG","year":"1978","unstructured":"Graham DG , TiffanySM , BellWR , GutknechtWF. Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol. Pharmacol.14(4), 644\u2013653 (1978).","journal-title":"Mol. Pharmacol."},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2018.01.074"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20010101)91:1 <221::AID-CNCR8>3.0.CO;2-9"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1101\/gr.8.12.1229"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1217876"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-012-0274-7"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.14.145"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2012.04.005"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-7274-6_27"}],"container-title":["Pharmacogenomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/pgs-2021-0023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T19:50:45Z","timestamp":1715975445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/pgs-2021-0023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":47,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["10.2217\/pgs-2021-0023"],"URL":"https:\/\/doi.org\/10.2217\/pgs-2021-0023","relation":{},"ISSN":["1462-2416","1744-8042"],"issn-type":[{"type":"print","value":"1462-2416"},{"type":"electronic","value":"1744-8042"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipgs20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipgs20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-02-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}